| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10969794 | Vaccine | 2011 | 5 Pages |
Abstract
⺠We evaluated influenza vaccine administered intradermallly (ID-TIV) in children. ⺠ID-TIV with 9 μg and virosmal TIV with 15 μg of antigens has similar immunogenicity. ⺠ID-TIV with 15 μg of each antigen confers the best protection against influenza. ⺠ID-TIV regardless of antigen dose appear to have an acceptable safety profile.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Susanna Esposito, Cristina Daleno, Irene Picciolli, Laura Tagliaferri, Alessia Scala, Giulia Prunotto, Valentina Montinaro, Carlotta Galeone, Nicola Principi,